Compare MIST & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | RVPH |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | N/A |
| IPO Year | 2019 | N/A |
| Metric | MIST | RVPH |
|---|---|---|
| Price | $1.44 | $0.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $8.00 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.17 |
| 52 Week High | $3.06 | $3.11 |
| Indicator | MIST | RVPH |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 24.73 |
| Support Level | $1.00 | $0.22 |
| Resistance Level | $2.30 | $0.66 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 2.46 | 13.17 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
REVIVA PHARMA HLDGS INC